Access restrictions apply.Some or all content stored offsite.
| Container | Contents | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BOX I:11-I:35 | Part I: Research File, 1917-1998 | ||||||||||||
| Correspondence, memoranda, reports, statements, studies, proposals, reviews, guidelines, reprints of articles, newspaper and magazine clippings, press releases, testimonies, minutes, and printed matter. | |||||||||||||
| Arranged alphabetically by subject, name of person or organization, or type of material and thereunder chronologically. | |||||||||||||
| BOX I:11 | 714X (Drug), |
||||||||||||
| BOX I:11 | Abel, John Jacob, biographical material, 1917-1968, undated | ||||||||||||
| BOX I:11 | Actinomycin C, 1963 | ||||||||||||
| BOX I:11 | Adrenocorticoids, undated | ||||||||||||
| BOX I:11 | Adverse Drug Effects Advisory Panel, 1975-1976, undated | ||||||||||||
| BOX I:11 | Adverse reaction reporting, 1955-1961, 1986-1988, undated | ||||||||||||
| BOX I:11 | Aldactone, 1975-1979 | ||||||||||||
| BOX I:11 | Aldomet, 1961, undated | ||||||||||||
| BOX I:11 | Ambodryl hydrochloride compound, 1961, undated | ||||||||||||
| BOX I:11 | American Arbitration Association, proposal for ethical review of investigational new drug studies, 1973-1974 | ||||||||||||
| BOX I:11 | American College of Neuropsychopharmacology, 1977 | ||||||||||||
| BOX I:11 | Arnold, John D., ethical problems of human experimentation in clinical drug trials, 1975-1988 | ||||||||||||
| BOX I:11 | Arthur D. Little, Inc., establishment of an integrated agency-wide scientific information system at the U.S. Food and Drug Administration, 1962-1965, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:11 | Avazyme, 1960-1962, undated | ||||||||||||
| BOX I:11 | Bamfolin, 1964 | ||||||||||||
| BOX I:12 | Bendectin, 1979-1981, 1998, undated | ||||||||||||
| (3 folders) | |||||||||||||
| BOX I:12 | Benoxaprofen, 1984 | ||||||||||||
| BOX I:12 | Billings, John Shaw, National Library of Medicine centennial, 1965 | ||||||||||||
| BOX I:12 | Bismuth sodium triglycollamate (Bistrimate), 1960-1966, undated | ||||||||||||
| BOX I:12 | Bureau of Drugs, U.S. Food and Drug Administration, 1971-1973, undated | ||||||||||||
| BOX I:12 | Chelation therapy, 1973-1985, undated | ||||||||||||
| BOX I:12 | Chloramphenicol, 1961-1968, undated | ||||||||||||
| BOX I:12 | Chlordiazepoxide hydrochloride, 1962, undated | ||||||||||||
| BOX I:12 | Committees | ||||||||||||
| BOX I:12 | Advisory Committee on Investigational Drugs | ||||||||||||
| BOX I:12 | 1962-1964 | ||||||||||||
| BOX I:13 | 1964-1966, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:13 | Advisory Committee on Protocols for Safety Evaluations, 1966-1967, undated | ||||||||||||
| BOX I:13 | Advisory Committee on Psychotomimetic Drugs, 1960-1968, undated | ||||||||||||
| BOX I:13 | Citizens Committee, 1960-1962, undated | ||||||||||||
| BOX I:13 | Research Involving Human Subjects Committee, 1970-1990 | ||||||||||||
| BOX I:13 | Congressional hearings | ||||||||||||
| BOX I:13 | House of Representatives | ||||||||||||
| BOX I:13 | Dingell, John D., investigation into acceptance of subsidized accommodations and related items by U.S. Food and Drug Administration officials, 1989 | ||||||||||||
| BOX I:13 | Fountain, L. H. (Lawrence), U.S. Food and Drug Administration's oversight of investigational new drugs | ||||||||||||
| BOX I:13 | 1963-1966 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:14 | 1966-1969, undated | ||||||||||||
| BOX I:14 | Gore, Albert (1948- ), ethics in biomedical research, 1981 | ||||||||||||
| (3 folders) | |||||||||||||
| BOX I:14 | Kastenmeier, Robert W., subject studies in vulnerable populations--prisoners, 1973-1975, 1981 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:14 | Senate | ||||||||||||
| BOX I:14 | Kefauver, Estes, investigation of drug industry, 1917, 1960-1962, undated | ||||||||||||
| BOX I:15 | Kennedy, Edward M., subject studies in vulnerable populations--prisoners, 1962-1978, undated | ||||||||||||
| (4 folders) | |||||||||||||
| BOX I:15 | Kennedy, Robert F., LSD (Drug), 1966-1969 | ||||||||||||
| BOX I:15 | Cumid, 1962, undated | ||||||||||||
| BOX I:15 | Cyclert, 1961-1962, undated | ||||||||||||
| BOX I:15 | Daroil, 1964-1966 | ||||||||||||
| BOX I:15 | De Haen, Paul, reports on new pharmaceutical products, 1963-1971 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:15 | Decadron, 1961-1962, undated | ||||||||||||
| BOX I:15 | Defoliants and herbicides, 1969-1971, 1996, undated | ||||||||||||
| BOX I:16 | DES (Drug) | ||||||||||||
| BOX I:16 | Correspondence, 1950-1978 | ||||||||||||
| BOX I:16 | Memoranda, 1970-1978 | ||||||||||||
| BOX I:16 | Miscellany, 1950-1978, undated | ||||||||||||
| BOX I:16 | Press releases, 1972 | ||||||||||||
| BOX I:16 | Printed matter, 1948-1985, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:16 | Reports and statements, 1972-1979, undated | ||||||||||||
| BOX I:16 | Task force, 1978 | ||||||||||||
| BOX I:16 | Diapulse device, 1967, 1995 | ||||||||||||
| BOX I:16 | Dihydrostreptomycin (DHSM), 1953, 1962, undated | ||||||||||||
| BOX I:16 | Division of Biologics Standards, U.S. Food and Drug Administration, 1972-1976 | ||||||||||||
| BOX I:16 | Division of Scientific Investigations, U.S. Food and Drug Administration, 1964, 1985-1987, undated | ||||||||||||
| BOX I:16 | DMSO (Drug) | ||||||||||||
| BOX I:16 | Bibliography, 1964 | ||||||||||||
| BOX I:16 | Correspondence, 1965-1967, 1980-1981 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:17 | Leake, Chauncey Depew, consulting editor, Biological Actions of Dimethyl Sulfoxide, 1967 | ||||||||||||
| BOX I:17 | McGrady, Pat, The Persecuted Drug: The Story of DMSO, 1980 | ||||||||||||
| BOX I:17 | Memoranda | ||||||||||||
| BOX I:17 | Conferences, 1965, 1980-1981 | ||||||||||||
| BOX I:17 | Miscellaneous, 1965-1966, 1980-1981 | ||||||||||||
| BOX I:17 | Office, 1964-1988 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:17 | Telephone conversations, 1965-1980 | ||||||||||||
| BOX I:17 | Miscellany, 1965, undated | ||||||||||||
| BOX I:17 | Press releases, 1964-1981 | ||||||||||||
| BOX I:18 | Printed matter, 1965-1982, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:18 | Reports and statements, 1965-1966, undated | ||||||||||||
| BOX I:18 | Subcommittee on Health and Scientific Research, Senate Committee on Labor and Human Resources, hearing and exhibits, 1980, undated | ||||||||||||
| BOX I:18 | Dornwal, 1961-1964, undated | ||||||||||||
| BOX I:18 | Drug efficacy study, National Academy of Sciences-National Research Council, 1969, undated | ||||||||||||
| BOX I:18 | Drug Research Board, National Academy of Sciences-National Research Council, 1965 | ||||||||||||
| BOX I:18 | Dyes, 1936, 1960-1989, undated | ||||||||||||
| BOX I:18 | Elavil, 1961-1963, undated | ||||||||||||
| BOX I:18 | Equal rights for women in the federal government, 1962-1972 | ||||||||||||
| BOX I:18 | Estrogenic substances in plants, 1959, undated | ||||||||||||
| BOX I:19 | Fluoridation, 1960-1979, 1990, undated | ||||||||||||
| (4 folders) | |||||||||||||
| BOX I:19 | Fluorouracil, 1961-1962, undated | ||||||||||||
| BOX I:19 | Furaltadone (Altafur), 1961 | ||||||||||||
| BOX I:19 | Galega, 1965-1967 | ||||||||||||
| BOX I:19 | Gestest, 1961, undated | ||||||||||||
| BOX I:19 | Hi and Dry (cream deodorant), 1961, undated | ||||||||||||
| BOX I:19 | Hypertension, 1961-1962, undated | ||||||||||||
| BOX I:19 | International Clearinghouse for Birth Defects Monitoring Systems, 1972-1978, undated | ||||||||||||
| BOX I:19 | Investigational Drug Branch, U.S. Food and Drug Administration, 1966 | ||||||||||||
| BOX I:19 | Investigational new drugs (INDs) | ||||||||||||
| BOX I:19 | Adverse comments, Division of Toxicological Evaluation, 1966 | ||||||||||||
| BOX I:19 | Comments on regulatory procedures, 1961-1975, undated | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:20 | Division of Oncology and Radiopharmaceutical Drug Products, U.S. Food and Drug Administration, 1966-1967 | ||||||||||||
| BOX I:20 | Inventory of early INDs, 1963 | ||||||||||||
| BOX I:20 | Proposed regulations and revisions, 1938, 1962-1975, undated | ||||||||||||
| BOX I:20 | Regulatory language, series form paragraphs, undated | ||||||||||||
| BOX I:20 | Treatment, 1981-1990 | ||||||||||||
| (2 folders) | |||||||||||||
| BOX I:20 | Kevadon See Container I:33 , Kevadon literature | ||||||||||||
| BOX I:20 | Krebiozen, 1959-1982, undated | ||||||||||||
| BOX I:20 | Lactostat and climacterin, 1961-1962, undated | ||||||||||||
| BOX I:21 | Laetrile, 1967-1983, undated | ||||||||||||
| (5 folders) | |||||||||||||
| BOX I:21 | Lavema, 1961, undated | ||||||||||||
| BOX I:21 | Leake, Chauncey Depew | ||||||||||||
| Next Page » | |||||||||||||